Overview
Astrocytoma, anaplastic, is a highly malignant brain tumor characterized by rapid growth and aggressive behavior, often requiring multimodal treatment approaches including surgery, radiation, and chemotherapy.Diagnosis
Imaging studies (MRI) essential for tumor localization and grading 1.
Histopathological examination confirms diagnosis and grading 1.
Neurological assessments to evaluate functional impact and guide treatment planning 1.Management
Surgery: Partial or gross total resection when feasible 1.
Radiation Therapy: Post-surgical adjuvant treatment to reduce tumor burden 1.
Chemotherapy: Lomustine (CCNU) commonly used, typically at doses of 200 mg/m2 on day 1 every 6 weeks 1.
Monitor for Toxicity: Closely monitor for hematological and multiorgan toxicities, especially after high-dose lomustine administration 1.Special Populations
Toxicity Monitoring: Increased vigilance required in all age groups for chemotherapy side effects, particularly multiorgan dysfunction 1.
No Specific Pediatric/Elderly Guidelines: Abstracts do not provide specific recommendations for pediatric or elderly patients 1.Key Recommendations
Avoid supplying more than the required dose of lomustine to prevent severe multiorgan toxicities (Evidence: Weak) 1.
Implement rigorous monitoring protocols for hematopoietic and organ function following lomustine administration (Evidence: Weak) 1.
Tailor supportive care based on individual patient response and organ function, especially in cases of suspected overdose (Evidence: Expert opinion) 1.References
1 Trent KC, Myers L, Moreb J. Multiorgan failure associated with lomustine overdose. The Annals of pharmacotherapy 1995. link
2 Vallés AM, White K. Development of serotonin-containing neurons in Drosophila mutants unable to synthesize serotonin. The Journal of neuroscience : the official journal of the Society for Neuroscience 1986. link